Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells

Toxicology Letters

Volumn 192, Issue 2, 2010, Pages 150-154

  Sugiyama, Kei ichi ^a   Muroi, Masashi ^b   Tanamoto, Ken ichi ^b   Nishijima, Motohiro ^c   Sugita Konishi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c JISSEN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Deoxynivalenol; Inducible nitric oxide synthase; Lipopolysaccharide; Macrophage; Nivalenol

Indexed keywords

BETA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NIVALENOL; VOMITOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME REPRESSION; IMMUNOTOXICITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; FUSARIUM; INTERFERON-BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MYCOTOXINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRICHOTHECENES;

FUNGI; FUSARIUM;

EID: 73749083169     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.10.020     Document Type: Article

References (35)

1. Amuzie C.J., Harkema J.R., and Pestka J.J. Tissue distribution and proinflammatory cytokine induction by the trichothecene deoxynivalenol in the mouse: comparison of nasal vs. oral exposure. Toxicology 248 (2008) 39-44
2. Bachmaier K., Neu N., Pummerer C., Duncan G.S., Mak T.W., Matsuyama T., and Penninger J.M. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 96 (1997) 585-591
3. Bae H.K., and Pestka J.J. Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages. Toxicol. Sci. 105 (2008) 59-66
4. Bennett J.W., and Klich M. Mycotoxins. Clin. Microbiol. Rev. 16 (2003) 497-516
5. Boockvar K.S., Granger D.L., Poston R.M., Maybodi M., Washington M.K., Hibbs Jr. J.B., and Kurlander R.L. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62 (1994) 1089-1100
6. Choi H.J., Eun J.S., Park Y.R., Kim D.K., Li R., Moon W.S., Park J.M., Kim H.S., Cho N.P., Cho S.D., and Soh Y. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways. Eur. J. Pharmacol. 601 (2008) 171-178
7. El Kasmi K.C., Qualls J.E., Pesce J.T., Smith A.M., Thompson R.W., Henao-Tamayo M., Basaraba R.J., Konig T., Schleicher U., Koo M.S., Kaplan G., Fitzgerald K.A., Tuomanen E.I., Orme I.M., Kanneganti T.D., Bogdan C., Wynn T.A., and Murray P.J. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9 (2008) 1399-1406
8. Haller O., Kochs G., and Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 (2006) 119-130
9. Instanes C., and Hetland G. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy. Toxicology 204 (2004) 13-21
10. Jacobs A.T., and Ignarro L.J. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J. Biol. Chem. 276 (2001) 47950-47957
11. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T.W., et al. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264 (1994) 1921-1924
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
13. Lee T., Han Y.K., Kim K.H., Yun S.H., and Lee Y.W. Tri13 and Tri7 determine deoxynivalenol- and nivalenol-producing chemotypes of Gibberella zeae. Appl. Environ. Microbiol. 68 (2002) 2148-2154
14. Li M., Harkema J.R., Cuff C.F., and Pestka J.J. Deoxynivalenol exacerbates viral bronchopneumonia induced by respiratory reovirus infection. Toxicol. Sci. 95 (2007) 412-426
15. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., and Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9730-9734
16. Miller B.H., Fratti R.A., Poschet J.F., Timmins G.S., Master S.S., Burgos M., Marletta M.A., and Deretic V. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect. Immun. 72 (2004) 2872-2878
17. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., and Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54 (1988) 903-913
18. Ohnishi T., Yoshida T., Igarashi A., Muroi M., and Tanamoto K. Effects of possible endocrine disruptors on MyD88-independent TLR4 signaling. FEMS Immunol. Med. Microbiol. 52 (2008) 293-295
19. Pestka J.J. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit. Contam. (2008) 1-13
20. Pestka J.J., and Amuzie C.J. Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice. Food Chem. Toxicol. 46 (2008) 2826-2831
21. Pestka J.J., and Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B: Crit. Rev. 8 (2005) 39-69
22. Rodel J., Groh A., Hartmann M., Schmidt K.H., Lehmann M., Lungershausen W., and Straube E. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts. Med. Microbiol. Immunol. 187 (1999) 205-212
23. Rotter B.A., Prelusky D.B., and Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 48 (1996) 1-34
24. Sakai K., Suzuki H., Oda H., Akaike T., Azuma Y., Murakami T., Sugi K., Ito T., Ichinose H., Koyasu S., and Shirai M. Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase. J. Biol. Chem. 281 (2006) 17736-17742
25. Shao L., Guo Z., and Geller D.A. Transcriptional suppression of cytokine-induced iNOS gene expression by IL-13 through IRF-1/ISRE signaling. Biochem. Biophys. Res. Commun. 362 (2007) 582-586
26. Shimomura-Shimizu M., Sugiyama K., Muroi M., and Tanamoto K. Alachlor and carbaryl suppress lipopolysaccharide-induced iNOS expression by differentially inhibiting NF-kappaB activation. Biochem. Biophys. Res. Commun. 332 (2005) 793-799
27. Sugita-Konishi Y., and Pestka J.J. Differential upregulation of TNF-alpha, IL-6, and IL-8 production by deoxynivalenol (vomitoxin) and other 8-ketotrichothecenes in a human macrophage model. J. Toxicol. Environ. Health A 64 (2001) 619-636
28. Tai J.H., and Pestka J.J. T-2 toxin impairment of murine response to Salmonella typhimurium: a histopathologic assessment. Mycopathologia 109 (1990) 149-155
29. Thomas K.E., Galligan C.L., Newman R.D., Fish E.N., and Vogel S.N. Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J. Biol. Chem. 281 (2006) 31119-31130
30. Tryphonas H., Iverson F., So Y., Nera E.A., McGuire P.F., O'Grady L., Clayson D.B., and Scott P.M. Effects of deoxynivalenol (vomitoxin) on the humoral and cellular immunity of mice. Toxicol. Lett. 30 (1986) 137-150
31. Xie Q.W., Whisnant R., and Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177 (1993) 1779-1784
32. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., and Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169 (2002) 6668-6672
33. Zheng H., Yu X., Collin-Osdoby P., and Osdoby P. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J. Biol. Chem. 281 (2006) 15809-15820
34. Zhou H.R., Harkema J.R., Yan D., and Pestka J.J. Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). J. Toxicol. Environ. Health A 57 (1999) 115-136
35. Ziprin R.L., and Elissalde M.H. Effect of T-2 toxin on resistance to systemic Salmonella typhimurium infection of newly hatched chickens. Am. J. Vet. Res. 51 (1990) 1869-1872